Venus concept announces closing of $1.2 million registered direct offering priced at-the-market under nasdaq rules

Toronto, feb. 27, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, today announced that it has closed its previously announced registered direct offering priced at-the-market under nasdaq rules for the purchase and sale of 817,748 shares of common stock at a purchase price of $1.465 per share. in a concurrent private placement, the company issued unregistered warrants to purchase up to 817,748 shares of common stock at an exercise price of $1.34 per share that are immediately exercisable upon issuance and will expire five years following the date of issuance.
VERO Ratings Summary
VERO Quant Ranking